373 related articles for article (PubMed ID: 28417594)
1. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
[TBL] [Abstract][Full Text] [Related]
2. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
[TBL] [Abstract][Full Text] [Related]
4. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
Cohen MG; Matthews R; Maini B; Dixon S; Vetrovec G; Wohns D; Palacios I; Popma J; Ohman EM; Schreiber T; O'Neill WW
Am Heart J; 2015 Nov; 170(5):872-9. PubMed ID: 26542494
[TBL] [Abstract][Full Text] [Related]
8. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
[TBL] [Abstract][Full Text] [Related]
10. Indication and short-term clinical outcomes of high-risk percutaneous coronary intervention with microaxial Impella® pump: results from the German Impella® registry.
Baumann S; Werner N; Ibrahim K; Westenfeld R; Al-Rashid F; Sinning JM; Westermann D; Schäfer A; Karatolios K; Bauer T; Becher T; Akin I
Clin Res Cardiol; 2018 Aug; 107(8):653-657. PubMed ID: 29520699
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.
Ait Ichou J; Larivée N; Eisenberg MJ; Suissa K; Filion KB
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1250-1260. PubMed ID: 28941078
[TBL] [Abstract][Full Text] [Related]
12. Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
Alraies MC; Kaki A; Kajy M; Blank N; Hasan R; Htun WW; Glazier JJ; Elder M; O'Neill WW; Grines CL; Schreiber T
Catheter Cardiovasc Interv; 2020 Sep; 96(3):536-544. PubMed ID: 31631515
[TBL] [Abstract][Full Text] [Related]
13. Complex High-Risk Indicated Percutaneous Coronary Intervention With Prophylactic Use of the Impella CP Ventricular Assist Device.
van den Buijs DMF; van den Brink FS; Wilgenhof A; Zivelonghi C; Verouden N; Knaapen P; Sjauw KD; Vermeersch P; Nap A
J Invasive Cardiol; 2022 Sep; 34(9):E665-E671. PubMed ID: 36001456
[TBL] [Abstract][Full Text] [Related]
14. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
Kovacic JC; Nguyen HT; Karajgikar R; Sharma SK; Kini AS
Catheter Cardiovasc Interv; 2013 Jul; 82(1):E28-37. PubMed ID: 21234916
[TBL] [Abstract][Full Text] [Related]
15. Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
Riley RF; McCabe JM; Kalra S; Lazkani M; Pershad A; Doshi D; Kirtane AJ; Nicholson W; Kearney K; Demartini T; Aaron Grantham J; Moses J; Lombardi W; Karmpaliotis D
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1261-1267. PubMed ID: 30019817
[TBL] [Abstract][Full Text] [Related]
16. First-in-human robotic percutaneous coronary intervention for unprotected left main stenosis.
Mahmud E; Dominguez A; Bahadorani J
Catheter Cardiovasc Interv; 2016 Oct; 88(4):565-570. PubMed ID: 27189238
[TBL] [Abstract][Full Text] [Related]
17. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
[TBL] [Abstract][Full Text] [Related]
18. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
[TBL] [Abstract][Full Text] [Related]
19. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
Doshi R; Patel K; Decter D; Jauhar R; Meraj P
Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
